NEXUS Low-Risk Criteria (C-Spine)
Five low-risk criteria to rule out cervical spine injury without imaging in blunt trauma patients. All criteria must be met to clear.
Score interpretation
→ All NEXUS criteria met; c-spine can be clinically cleared
→ One or more criteria not met; obtain CT c-spine
Interpretation bands for the NEXUS C-Spine. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Tranexamic Acid (ICU/Trauma/Surgical) · Antifibrinolytic
- Dinoprostone (Cervical Ripening / Induction of Labour) · Prostaglandin E2 (Cervical Ripening / Induction of Labour)
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Tranexamic Acid (Surgical / Trauma Haemorrhage) · Antifibrinolytic (Haemostatic)
Featured in these MRCEM clinical pathways
The NEXUS C-Spine is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.